TY - JOUR
T1 - New, diagnostic flicker test for optic neuritis shows specific stages following disease onset
AU - Pihl-Jensen, Gorm
AU - Trauzettel-Klosinski, Susanne
AU - Wanscher, Benedikte
AU - Frederiksen, Jette
N1 - Publisher Copyright:
© 2022
PY - 2022/12
Y1 - 2022/12
N2 - Background: Previously, results of the digital flicker test (DFT) have shown distinct patterns in acute optic neuritis (ON) and healthy eyes. We aimed to examine the diagnostic potential of the DFT in acute ON and to investigate the temporal development of the DFT response following ON while comparing with visual evoked potentials (VEP). Methods: The DFT examines the subjective brightness of a flickering field, varied in 11 different frequencies from 0 to 60 Hz, compared to a steady field. Previous studies have indicated a pronounced darkness enhancement at medial frequencies in acute ON eyes. Darkness enhancement at medial frequencies was expressed as a quantitative covariate (DFTDE). Results were compared with healthy controls and follow-up measurements were compared with VEP. Results: 112 patients were examined <31 days of onset (median 14.0 days (IQR:12.25)). 104 of 112 patients showed an abnormal flicker test (sensitivity 93%). DFT was abnormal in 2 of 55 healthy controls. The DFT showed normalization in 34% at 3 months, 36.4% at 6 months and 71.4% at >8 months from ON onset compared to 13.3%, 22.4% and 28.6% for VEP. Changes to the pattern of the DFT results were shown at specific stages during and following ON. Conclusions: The DFT is an easy-to-use and sensitive diagnostic test for acute ON. The flicker test shows a more pronounced temporal evolution following ON than VEP and may be of use monitoring the course of ON.
AB - Background: Previously, results of the digital flicker test (DFT) have shown distinct patterns in acute optic neuritis (ON) and healthy eyes. We aimed to examine the diagnostic potential of the DFT in acute ON and to investigate the temporal development of the DFT response following ON while comparing with visual evoked potentials (VEP). Methods: The DFT examines the subjective brightness of a flickering field, varied in 11 different frequencies from 0 to 60 Hz, compared to a steady field. Previous studies have indicated a pronounced darkness enhancement at medial frequencies in acute ON eyes. Darkness enhancement at medial frequencies was expressed as a quantitative covariate (DFTDE). Results were compared with healthy controls and follow-up measurements were compared with VEP. Results: 112 patients were examined <31 days of onset (median 14.0 days (IQR:12.25)). 104 of 112 patients showed an abnormal flicker test (sensitivity 93%). DFT was abnormal in 2 of 55 healthy controls. The DFT showed normalization in 34% at 3 months, 36.4% at 6 months and 71.4% at >8 months from ON onset compared to 13.3%, 22.4% and 28.6% for VEP. Changes to the pattern of the DFT results were shown at specific stages during and following ON. Conclusions: The DFT is an easy-to-use and sensitive diagnostic test for acute ON. The flicker test shows a more pronounced temporal evolution following ON than VEP and may be of use monitoring the course of ON.
UR - http://www.scopus.com/inward/record.url?scp=85141544880&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2022.104254
DO - 10.1016/j.msard.2022.104254
M3 - Journal article
C2 - 36544316
AN - SCOPUS:85141544880
SN - 2211-0348
VL - 68
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
M1 - 104254
ER -